Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-11 10:12 am Sale | 13G | CODEXIS INC CDXS | Casdin Capital LLC | 4,330,000 6.82% | -743,780 (-14.66%) | View |
| 2020-11-27 5:21 pm Purchase | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital LLC | 7,440,107 22.7% | 3,066,774 (+70.12%) | View |
| 2020-06-01 1:14 pm Purchase | 13G | DERMTECH INC DMTK | Casdin Capital LLC | 1,428,571 7.9% | 1,428,571 (New Position) | View |
| 2020-05-18 6:15 pm Purchase | 13G | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital LLC | 4,373,333 18.2% | 1,904,762 (+77.16%) | View |
| 2020-05-18 4:18 pm Sale | 13D | GenMark Diagnostics Inc. GNMK | Casdin Capital LLC | 2,555,000 4.1% | -810,000 (-24.07%) | View |
| 2020-04-07 09:48 am Purchase | 13G | INVITAE CORP COM NVTAQ | Casdin Capital LLC | 9,033,943 7.7% | 9,033,943 (New Position) | View |
| 2020-02-20 4:10 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | Casdin Capital LLC | 1,239,285 5.3% | 1,239,285 (New Position) | View |
| 2020-02-07 4:11 pm Sale | 13D | GenMark Diagnostics Inc. GNMK | Casdin Capital LLC | 3,365,000 5.8% | -485,000 (-12.60%) | View |
| 2020-02-06 5:29 pm Purchase | 13G | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital LLC | 2,468,571 12.1% | 40,000 (+1.65%) | View |
| 2020-02-06 5:28 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Casdin Capital LLC | 3,098,122 7.9% | 454,804 (+17.21%) | View |
| 2020-02-06 5:27 pm Purchase | 13G | Gritstone bio Inc. GRTS | Casdin Capital LLC | 2,160,000 6% | 260,000 (+13.68%) | View |
| 2020-02-06 5:26 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS INC CNST | Casdin Capital LLC | 1,212,734 2.9% | -344,265 (-22.11%) | View |
| 2019-11-21 12:25 pm Purchase | 13G | Gritstone bio Inc. GRTS | Casdin Capital LLC | 1,900,000 5.3% | 1,900,000 (New Position) | View |
| 2019-06-25 4:43 pm Purchase | 13G | CODEXIS INC CDXS | Casdin Capital LLC | 5,073,780 8.8% | 5,073,780 (New Position) | View |